A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer
Article in Future Oncology (May 2022)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in Future Oncology (May 2022)
Article in JAMA Oncology (April 2022)
Article in Open Access Macedonian Journal of Medical Sciences (February 2022)